AMY ALMANY: Open Payments
NPI 1730699505 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 62 payments from 22 companies in 2025. Trend: 2023 $2,065 · 2024 $1,840 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $302 |
| GlaxoSmithKline, LLC. | 12 | $160 |
| Novo Nordisk Inc | 6 | $117 |
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| ABBVIE INC. | 4 | $89 |
| PFIZER INC. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Amgen Inc. | 4 | $62 |
| Exact Sciences Corporation | 2 | $44 |
| Corcept Therapeutics | 2 | $44 |
Products named: TEZSPIRE, TRELEGY ELLIPTA, DUPIXENT, LEQVIO, PREVNAR 20, UBRELVY, OTEZLA, Cologuard Collection Kit.
Industry payments across VA — which companies pay providers there.
